Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biopolis is a leading Spanish microbial biotechnology company specializing in contract research, development, and manufacturing services for the agri-food, pharmaceutical, chemical, feed, energy/environmental sectors. It offers expertise in isolation/design/production of microorganisms/metabolites including probiotics and recombinant proteins. Notable IP includes patented probiotic strains targeting obesity/diabetes. The company was acquired by Archer Daniels Midland Company but continues to operate under the "ADM Biopolis" brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biopolis.